如要提出意见建议,请到社区论坛发帖反馈。

约有710篇,以下是第111-120 排序:相关性|最多阅读|最新上传

20 Pages
Stimulating Innovation in the Biologics Industry_ A Balanced Approach to Marketing Exclusivity.pdf
Stimulating Innovation in the Biologics Industry_ A Balanced Approach to Marketing Exclusivity.pdfin,A,to,the
26 Pages
Guidance for Industry Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
  • 0
  • mbt2000 2010-10-26 11:27
  • 热度: 格式: pdf
20 Pages
Multiplicity Issues in Biologics Clinical Trials Regulatory 在生物多样性临床试验的监管问题
Multiplicity Issues in Biologics Clinical Trials Regulatory 在生物多样性临床试验的监管问题论文 总结 英语 资料 ppt 文档 免费阅读 免费分享,如需请下载!
28 Pages
follow-on biologics intellectual property and innovation:后续生物制剂的知识产权和创新
follow-on biologics intellectual property and innovation:后续生物制剂的知识产权和创新
  • 0
  • qingrencrh 2016-05-31 15:12
  • 热度: 格式: pdf
21 Pages
Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics Implications for Immunogenicity of Pharmaceutical Proteins
Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics Implications for Immunogenicity of Pharmaceutical Proteins
  • 0
  • 567722 2015-12-21 22:33
  • 热度: 格式: pdf
13 Pages
Biosimilars and Follow-On Biologics Global Market Outlook 2010-2025 - opportunities and challenges in this emerging market with high potential
imilars and follow-on biologics seize market share - our new report explains how. Many biologic patents will expire during our forecast period. There is mounting pressure from governments, insurers an...
28 Pages
primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammato
primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammato
  • 0
  • yakii2008 2018-02-09 17:56
  • 热度: 格式: pdf
29 Pages
Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics_ The importance of physician-patient interaction a
Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics_ The importance of physician-patient interaction a
  • 0
  • 316072725c 2017-03-22 14:15
  • 热度: 格式: pdf
25 Pages
fusion proteins for half-life extension of biologics as a strategy to make biobetters:融合蛋白的生物半衰期延长一个策略让biobetters
fusion proteins for half-life extension of biologics as a strategy to make biobetters:融合蛋白的生物半衰期延长一个策略让biobetters
  • 0
  • aelziwn702 2015-11-13 00:42
  • 热度: 格式: pdf
21 Pages
a systematic review of pharmacogenetic studies on the response to biologics in psoriasis patients.[2017][br j dermatol][10.1111bjd.15753]
a systematic review of pharmacogenetic studies on the response to biologics in psoriasis patients.[2017][br j dermatol][10.1111bjd.15753]
  • 0
  • wxwmlgb 2017-06-25 19:52
  • 热度: 格式: pdf

向豆丁求助:有没有biologics?